{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:23Z","timestamp":1787032883437,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,13]]},"DOI":"10.7759\/cureus.46957","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:35:09Z","timestamp":1697182509000},"source":"Crossref","is-referenced-by-count":2,"title":["Embolic Phenomena of Libman-Sacks Endocarditis and Antiphospholipid Syndrome"],"prefix":"10.7759","author":[{"given":"Asher","family":"Gorantla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schaible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi  S","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandita","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Andrew-Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varshitha","family":"Panduranga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S","family":"Budzikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14740\/cr534e","article-title":"Lupus-negative Libman-Sacks endocarditis complicated by catastrophic antiphospholipid syndrome","volume":"8","author":"Murtaza G","year":"2017","unstructured":"Murtaza G, Iskandar J, Humphrey T, Adhikari S, Kuruvilla A. Lupus-negative Libman-Sacks endocarditis complicated by catastrophic antiphospholipid syndrome. Cardiol Res. 2017, 8:57-62. 10.14740\/cr534e","journal-title":"Cardiol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2007.07.029","article-title":"Non-bacterial thrombotic endocarditis","volume":"32","author":"Asopa S","year":"2007","unstructured":"Asopa S, Patel A, Khan OA, Sharma R, Ohri SK. Non-bacterial thrombotic endocarditis. Eur J Cardiothorac Surg. 2007, 32:696-701. 10.1016\/j.ejcts.2007.07.029","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine JS","year":"2002","unstructured":"Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002, 346:752-63. 10.1056\/NEJMra002974","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.93.8.1579","article-title":"Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome","volume":"93","author":"Hojnik M","year":"1996","unstructured":"Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996, 93:1579-87. 10.1161\/01.cir.93.8.1579","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2013.04.012","article-title":"Libman-Sacks endocarditis and embolic cerebrovascular disease","volume":"6","author":"Roldan CA","year":"2013","unstructured":"Roldan CA, Sibbitt WL Jr, Qualls CR, et al.. Libman-Sacks endocarditis and embolic cerebrovascular disease. JACC Cardiovasc Imaging. 2013, 6:973-83. 10.1016\/j.jcmg.2013.04.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-5-518","article-title":"Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment","volume":"12","author":"el-Shami K","year":"2007","unstructured":"el-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. Oncologist. 2007, 12:518-23. 10.1634\/theoncologist.12-5-518","journal-title":"Oncologist"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2015.02.011","article-title":"Libman-Sacks endocarditis: Detection, characterization, and clinical correlates by three-dimensional transesophageal echocardiography","volume":"28","author":"Roldan CA","year":"2015","unstructured":"Roldan CA, Tolstrup K, Macias L, Qualls CR, Maynard D, Charlton G, Sibbitt WL Jr. Libman-Sacks endocarditis: Detection, characterization, and clinical correlates by three-dimensional transesophageal echocardiography. J Am Soc Echocardiogr. 2015, 28:770-9. 10.1016\/j.echo.2015.02.011","journal-title":"J Am Soc Echocardiogr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22066","article-title":"Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature","volume":"65","author":"Andreoli L","year":"2013","unstructured":"Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, Ramire de Jesus G, Erkan D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res (Hoboken). 2013, 65:1869-73. 10.1002\/acr.22066","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera R","year":"2002","unstructured":"Cervera R, Piette JC, Font J, et al.. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002, 46:1019-27. 10.1002\/art.10187","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"Libman-Sacks endocarditis: Detection, characterization, and clinical correlates by three-dimensional transesophageal echocardiography","volume":"71","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. Libman-Sacks endocarditis: Detection, characterization, and clinical correlates by three-dimensional transesophageal echocardiography. Arthritis Rheumatol. 2019, 71:1400-12. 10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/art.20120","article-title":"The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus","volume":"50","author":"McClain MT","year":"2004","unstructured":"McClain MT, Arbuckle MR, Heinlen LD, et al.. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum. 2004, 50:1226-32. 10.1002\/art.20120","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002534","article-title":"Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study","volume":"9","author":"Laurent C","year":"2023","unstructured":"Laurent C, Ricard L, Nguyen Y, et al.. Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study. RMD Open. 2023, 9:10.1136\/rmdopen-2022-002534","journal-title":"RMD Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou MG","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, et al.. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019, 78:1296-304. 10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.185132","article-title":"Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban","volume":"103","author":"Martinelli I","year":"2018","unstructured":"Martinelli I, Abbattista M, Bucciarelli P, et al.. Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban. Haematologica. 2018, 103:e315-7. 10.3324\/haematol.2017.185132","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30079-5","article-title":"Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2\/3, non-inferiority trial","volume":"3","author":"Cohen H","year":"2016","unstructured":"Cohen H, Hunt BJ, Efthymiou M, et al.. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2\/3, non-inferiority trial. Lancet Haematol. 2016, 3:e426-36. 10.1016\/S2352-3026(16)30079-5","journal-title":"Lancet Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221118463","article-title":"Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: a meta-analysis of randomized controlled trials","volume":"31","author":"Lee YH","year":"2022","unstructured":"Lee YH, Song GG. Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: a meta-analysis of randomized controlled trials. Lupus. 2022, 31:1335-43. 10.1177\/09612033221118463","journal-title":"Lupus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials","volume":"81","author":"Khairani CD","year":"2023","unstructured":"Khairani CD, Bejjani A, Piazza G, et al.. Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J Am Coll Cardiol. 2023, 81:16-30. 10.1016\/j.jacc.2022.10.008","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005808","article-title":"Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial","volume":"6","author":"Woller SC","year":"2022","unstructured":"Woller SC, Stevens SM, Kaplan D, et al.. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv. 2022, 6:1661-70. 10.1182\/bloodadvances.2021005808","journal-title":"Blood Adv"},{"key":"ref19","article-title":"Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study","volume":"31","author":"Zavaleta NE","year":"2004","unstructured":"Zavaleta NE, Montes RM, Soto ME, Vanzzini NA, Amigo MC. Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study. J Rheumatol. 2004, 31:2402-7.","journal-title":"J Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-5-13","article-title":"Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature","volume":"5","author":"Bouma W","year":"2010","unstructured":"Bouma W, Klinkenberg TJ, van der Horst IC, et al.. Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature. J Cardiothorac Surg. 2010, 5:13. 10.1186\/1749-8090-5-13","journal-title":"J Cardiothorac Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/192275-embolic-phenomena-of-libman-sacks-endocarditis-and-antiphospholipid-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:09:10Z","timestamp":1707491350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/192275-embolic-phenomena-of-libman-sacks-endocarditis-and-antiphospholipid-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.46957","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,13]]}}}